This inventor holds 38 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Astrazeneca Ab, Astra Lakemedel Aktiebolag, Astra Aktiebolag. Active years: 1976-2008.
Location History:
- Sodertalje, S (1976)
- 52 Sodertalje, SE (1978)
- Sodertalje, SE (1976 - 2000)
- Södertälje, SE (2001 - 2008)
Company Filing History:
15 out of 1,531 
11 out of 68 
9 out of 271 
Years Active: 1976-2008
Areas of Expertise:
Title: Innovations and Contributions of Svante Bertil Ross
Introduction
Svante Bertil Ross, a prominent innovator based in Sodertalje, Sweden, holds a remarkable portfolio of 36 patents. His work primarily focuses on the development of pharmaceutical compounds, specifically in the area of indan and chroman derivatives. This article explores his latest patents, career highlights, and collaborations with other industry professionals.
Latest Patents
Ross's latest patents showcase his expertise in synthesizing innovative chemical compounds. One notable invention is related to "Substituted indan derivatives," which pertains to intermediates that are crucial for preparing piperazinyl-substituted indan derivatives. Another significant patent focuses on "Substituted chroman derivatives," involving new piperidyl- or piperazinyl-substituted dihydro-2H-1-benzopyran derivatives. These advancements hold potential for further developments in medicinal chemistry.
Career Highlights
Throughout his career, Ross has made significant contributions while working with renowned companies, including AstraZeneca AB and Astra Aktiebolag. His efforts in these organizations have enhanced pharmaceutical research and development, aligning with the industry's drive for innovative drug solutions.
Collaborations
Ross has collaborated with distinguished colleagues, including Seth-Olov Thorberg and Stefan Berg. These partnerships have fostered a creative environment, leading to advancements in chemical research and patentable inventions. Working alongside such talented individuals, Ross has been able to extend his expertise and influence in the field.
Conclusion
Svante Bertil Ross exemplifies the potential of innovations in the pharmaceutical industry through his extensive patent portfolio and collaborative efforts. His work with companies like AstraZeneca AB and his partnerships with fellow researchers highlight the importance of teamwork and creativity in driving advancements forward. The impact of his contributions continues to resonate within the field of pharmaceutical research, paving the way for future developments.